Screening for bipolar disorder among migraineurs: The impact of migraine–bipolar disorder comorbidity on disease characteristics

Neuropsychiatric Disease and Treatment

Volumn 13, Issue , 2017, Pages 631-641

  Kivilcim, Yigit ^a   Altintas, Merih ^a   Domac, Fusun Mayda ^a   Erzincan, Erkal ^a   Giilec, Huseyin ^a  

^a Erenkoy Mental and Neurologic Disease Training and Research Hospital   (Turkey)

Author keywords

Bipolar disorder; Comorbidity; Depression; MIDAS; Migraine; Suicide attempt

Indexed keywords

ADULT; ANXIETY; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; FAMILY HISTORY; FEMALE; HUMAN; HYPOMANIA CHECKLIST 32; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDAS (MIGRAINE); MIGRAINE; MOOD DISORDER QUESTIONNAIRE; PHYSICAL ABUSE; PSYCHOSIS; SCREENING TEST; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUICIDE ATTEMPT; TERTIARY CARE CENTER;

EID: 85014524850     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S121448     Document Type: Article

References (55)

1. Lipton RB, Bigal ME, Steiner TJ, Silberstein SD, Olesen J. Classification of primary headaches. Neurology. 2004; 63 (3): 427–435.
2. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 3rd edition (beta version). Cephalalgia. 2013; 33: 629–808.
3. Vecchia D, Pietrobon D. Migraine: a disorder of brain excitatory-inhibitory balance? Trends Neurosci. 2012; 35: 507–520.
4. Ratcliffe GE, Enns MW, Jacobi F, Belik SL, Sareen J. The relationship between migraine and mental disorders in a population-based sample. Gen Hosp Psychiatry. 2009; 31 (1): 14–19.
5. Rathnasiri Bandara SM. Migraine and psychiatric disorders co-morbidity explained by sinus hypoxic nitric oxide theory-a new hypothesis on the Sino rhinogenic theory. Med Hypotheses. 2014; 82 (3): 257–265.
6. Minen MT, Tanev K. Influence of psychiatric comorbidities in migraineurs in the emergency department. Gen Hosp Psychiatry. 2014; 36 (5): 533–538.
7. Baskin SM, Smitherman TA. Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurol Sci. 2009; 30 (suppl 1): S61–S65.
8. Ketter TA. Diagnostic features, prevalence, and impact of bipolar disorder. J Clin Psychiatry. 2010; 71 (6): e14.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
10. McIntyre RS, Konarski JZ, Wilkins K, Bouffard B, Soczynska JK, Kennedy SH. The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey. Headache. 2006; 46 (6): 973–982.
11. Fornaro M, De Berardis D, De Pasquale C, et al. Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: a systematic review. Compr Psychiatry. 2015; 56: 1–16.
12. Brietzke E, Moreira CL, Duarte SV, et al. Impact of comorbid migraine on the clinical course of bipolar disorder. Compr Psychiatry. 2012; 53 (6): 809–812.
13. Ibiloglu AO, Caykoylu A. The comorbidity of migraine in bipolar disorder. JMOOD. 2011; 1: 25–33.
14. Leo RJ, Singh J. Migraine headache and bipolar disorder comorbidity: a systematic review of the literature and clinical implications. Scand J Pain. 2016; 11: 136–145.
15. Low NC, Du Fort GG, Cervantes P. Prevalence, clinical correlates, and treatment of migraine in bipolar disorder. Headache. 2003; 43 (9): 940–949.
16. Ortiz A, Cervantes P, Zlotnik G, et al. Cross-prevalence of migraine and bipolar disorder. Bipolar Disord. 2010; 12 (4): 397–403.
17. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry. 1990; 47 (9): 849–853.
18. Semiz M, Şentürk IA, Balaban H, Yağız AK, Kavakçı Ö. Prevalence of migraine and co-morbid psychiatric disorders among students of Cumhuriyet University. J Headache Pain. 2013; 14: 34.
19. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington, DC: American Psychiatric Press; 1997.
20. Ozkurkcugil A, Aydemir Ö, Yıldız M, Danacı E, Köroğlu E. Adaptation and reliability study of structured clinical interview for DSM-IV axis I disorders. Turk J Drug Ther. 1999; 12: 233–236.
21. Ozerdem A, Yazici O, Oral ET, et al; The Mood Disorders Study Group Psychiatric Association of Turkey. Establishment of a registry program for bipolar illness in Turkey. International Society of Affective Disorders 2nd Biennial Conference-Cancun, Mexico. J Affect Disord. 2004; 78 (suppl 1): 86.
22. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000; 157 (11): 1873–1875.
23. Konuk N, Kıran S, Tamam L, Karaahmet E, Aydın H, Atik L. Validation of the Turkish version of the “Mood Disorder Questionnaire” for the screening of bipolar disorders. Türk Psikiyatri Derg. 2007; 18: 147–154.
24. Angst J, Adolfsson R, Benazzi F, et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005; 88 (2): 217–233.
25. Vahip S, Aydemir O, Akkaya C, et al. Reliability and validity study of the Turkish version of hypomania checklist-32-revised. Türk Psikiyatri Derg. 2016; 27: 1–10.
26. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001; 15 (6 suppl 1): 20–28.
27. Ertas M, Siva A, Dalkara T, et al; Turkish MIDAS Group. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2004; 44 (8): 786–793.
28. Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011; 68 (3): 241–251.
29. Yazici O. Bipolar-I and bipolar-II disorders. In: Köroglu E, Gülec C, editors. Essentials Book of Psychiatry. 2nd ed. Ankara: HYB Press; 2007: 273.
30. İbiloğlu AO, Cayköylü A. Distinctive sociodemographic, clinical and temperament characteristics of bipolar-I, bipolar-II and major depressive disorders. Turk Psikiyatri Derg. 2011; 22: 159–165.
31. Chiaroni P, Hantouche EG, Gouvernet J. Hyperthymic and depressive temperaments study in controls, as a function of their familial loading for mood disorders. Encephale. 2004; 30: 509–514.
32. Franchini L, Bongiorno F, Dotoli D, Rainero I, Pinessi L, Smeraldi E. Migraine headache and mood disorders: a descriptive study in an outpatient psychiatric population. J Affect Disord. 2004; 81 (2): 157–160.
33. Sucksdorff D, Brown AS, Chudal R, Heinimaa M, Suominen A, Sourander A. Parental and comorbid migraine in individuals with bipolar disorder: a nationwide register study. J Affect Disord. 2016; 206: 109–114.
34. Victor TW, Hu X, Campbell J, White RE, Buse DC, Lipton RB. Association between migraine, anxiety and depression. Cephalalgia. 2010; 30 (5): 567–575.
35. Louter MA, Pijpers JA, Wardenaar KJ, et al. Symptom dimensions of affective disorders in migraine patients. J Psychosom Res. 2015; 79 (5): 458–463.
36. Dilsaver SC, Benazzi F, Oedegaard KJ, Fasmer OB, Akiskal HS. Is a family history of bipolar disorder a risk factor for migraine among affectively ill patients? Psychopathology. 2009; 42 (2): 119–123.
37. Fornaro M, De Berardis D, Iasevoli F, et al. Treatment adherence towards prescribed medications in bipolar-II acute depressed patients: relationship with cyclothymic temperament and “therapeutic sensation seeking” in response towards subjective intolerance to pain. J Affect Disord. 2013; 151: 596–604.
38. Fornaro M, Martino M, De Pasquale C, Moussaoui D. The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? Expert Opin Pharmacother. 2012; 13: 2037–2051.
39. Fornaro M, Stubbs B. A meta-analysis investigating the prevalence and moderators of migraines among people with bipolar disorder. J Affect Disord. 2015; 178: 88–97.
40. Subramaniam M, Abdin E, Vaingankar JA, Chong SA. Prevalence, correlates, comorbidity and severity of bipolar disorder: results from the Singapore Mental Health Study. J Affect Disord. 2013; 146 (2): 189–196.
41. Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatr Serv. 2009; 60 (2): 147–156.
42. Laursen TM, Munk-Olsen T, Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One. 2011; 6: e24597.
43. Chang JC, Chen HH, Yen AM, Chen SL, Lee CS. Survival of bipolar depression, other type of depression and comorbid ailments: ten-year longitudinal follow-up of 10, 922 Taiwanese patients with depressive disorders (KCIS no PSY1). J Psychiatr Res. 2012; 46: 1442–1448.
44. Pompili M, Gonda X, Serafini G, et al. Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord. 2013; 15 (5): 457–490.
45. Berkol TD, İslam S, Kırlı E, Pınarbaşı R, Özyıldırım İ. Suicide attempts and clinical features of bipolar patients. Saudi Med J. 2016; 37 (6): 662–667.
46. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991; 37 (1): 11–23.
47. Oztürk MO. Mental Health and Disorders. Ankara: Nobel Medical Bookstore; 2002: 292–428.
48. Kayhan F, Ilik F. Prevalence of personality disorders in patients with chronic migraine. Compr Psychiatry. 2016; 68: 60–64.
49. Fuller-Thomson E, Baker TM, Brennenstuhl S. Investigating the association between childhood physical abuse and migraine. Headache. 2010; 50 (5): 749–760.
50. Levitan RD, Parikh SV, Lesage AD, et al. Major depression in individuals with a history of childhood physical or sexual abuse: relationship to neurovegetative features, mania, and gender. Am J Psychiatry. 1998; 155: 1746–1752.
51. Post RM, Altshuler LL, Leverich GS, et al. Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder. J Affect Disord. 2013; 147 (1–3): 288–294.
52. Meyer TD, Bernhard B, Born C, et al. The hypomania checklist-32 and the Mood Disorder Questionnaire as screening tools-going beyond samples of purely mood-disordered patients. J Affect Disord. 2011; 128 (3): 291–298.
53. Chou CC, Lee IH, Yeh TL, et al. Comparison of the validity of the Chinese versions of the Hypomania Symptom Checklist-32 (HCL-32) and Mood Disorder Questionnaire (MDQ) for the detection of bipolar disorder in medicated patients with major depressive disorder. Int J Psychiatry Clin Pract. 2012; 16 (2): 132–137.
54. Oedegaard KJ, Fasmer OB. Is migraine in unipolar depressed patients a bipolar spectrum trait? J Affect Disord. 2005; 84 (2–3): 233–242.
55. Lee K, Oh H, Lee EH, Kim JH, Kim JH, Hong KS. Investigation of the clinical utility of the hypomania checklist 32 (HCL-32) for the screening of bipolar disorders in the non-clinical adult population. BMC Psychiatry. 2016; 16: 124.